Literature DB >> 12899620

Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding.

Michael R Wester1, Eric F Johnson, Cristina Marques-Soares, Sylvie Dijols, Patrick M Dansette, Daniel Mansuy, C David Stout.   

Abstract

The structure of the anti-inflammatory drug diclofenac bound in the active site of rabbit microsomal cytochrome P450 2C5/3LVdH was determined by X-ray crystallography to 2.1 A resolution. P450 2C5/3LVdH and the related enzyme 2C5dH catalyze the 4'-hydroxylation of diclofenac with apparent K(m) values of 80 and 57 microM and k(cat) values of 13 and 16 min(-1), respectively. Spectrally determined binding constants are similar to the K(m) values. The structure indicates that the pi-electron system of the dichlorophenyl moiety faces the heme Fe with the 3'- and 4'-carbons located 4.4 and 4.7 A, respectively, from the Fe. The carboxyl moiety of the substrate is hydrogen bonded to a cluster of waters that are also hydrogen bonded to the side chains of N204, K241, S289, and D290 as well as the backbone of the protein. The proximity of the diclofenac carboxylate to the side chain of D290 together with an increased binding affinity at lower pH suggests that diclofenac is protonated when bound to the enzyme. The structure exhibits conformational changes indicative of an adaptive fit to the substrate reflecting both the hydration and size of the substrate. These results indicate how structurally diverse substrates are recognized by drug-metabolizing P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899620     DOI: 10.1021/bi034556l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  Cytochrome P450 flexibility.

Authors:  Thomas L Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 2.  Tyrosine kinase inhibitors and drug interactions: a review with practical recommendations.

Authors:  Bella Pajares; Esperanza Torres; José Manuel Trigo; María Isabel Sáez; Nuria Ribelles; Begoña Jiménez; Emilio Alba
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

Review 3.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

4.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

5.  Conformational equilibrium of cytochrome P450 BM-3 complexed with N-palmitoylglycine: a replica exchange molecular dynamics study.

Authors:  Krishna Pratap Ravindranathan; Emilio Gallicchio; Richard A Friesner; Ann E McDermott; Ronald M Levy
Journal:  J Am Chem Soc       Date:  2006-05-03       Impact factor: 15.419

6.  The effect of a tightly bound water molecule on scaffold diversity in the computer-aided de novo ligand design of CDK2 inhibitors.

Authors:  Alfonso T García-Sosa; Ricardo L Mancera
Journal:  J Mol Model       Date:  2005-12-23       Impact factor: 1.810

Review 7.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

Review 8.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

9.  Two-dimensional NMR and all-atom molecular dynamics of cytochrome P450 CYP119 reveal hidden conformational substates.

Authors:  Jed N Lampe; Relly Brandman; Santhosh Sivaramakrishnan; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

10.  Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.

Authors:  Sivananthaperumal Shanmugasundararaj; Xiaojuan Zhou; Jens Neunzig; Rita Bernhardt; Joseph F Cotten; Rile Ge; Keith W Miller; Douglas E Raines
Journal:  Anesth Analg       Date:  2013-03-14       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.